glp-1 announcement today Good news, trypanophobics (people afraid of needles). Novo Nordisk now offers a weight-loss drug that's a little easier to swallow. The drugmaker announced it's launching its daily Wegovy pill in the Novo Nordisk, Eli Lilly roll

The major target of insulin/IGF-1 signaling might be mTOR and its connection to STAT3 (Fig

A recent KFF poll of all adults (insured and uninsured) showed that insurance covered all of the cost for GLP-1 agonists for 1 out of 4 patients using them according to self-reported responses, but over half (54%) of adults taking these drugs had difficulty paying for them

10.1016/S0021-9258(18)34798-7 14

Simply take one capsule a day with a glass of water outside of a meal

This melon has a long shelf-life, theorized to be in part because of high SOD activity (and therefore cellular longevity) in the living fruit

One of the key players in this equation might just be a powerful antioxidant known as glutathione